In human NSCLC H2030 cells, the siRNAs targeting exons 7 and 2 of HIPK2 reduced the protein level of HIPK2 isoform 3 (110 kDa) and decreased YAP protein and its downstream CTGF protein levels. Here, HIPK2 is linked to non-small cell lung carcinoma.